Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)

SHA:603590 Revenue

Beijing Konruns Pharmaceutical had revenue of 231.35M CNY in the quarter ending September 30, 2025, a decrease of -4.12%. This brings the company's revenue in the last twelve months to 871.31M, up 2.96% year-over-year. In the year 2024, Beijing Konruns Pharmaceutical had annual revenue of 825.40M, down -10.28%.

• Revenue (ttm): 871.31M
• Revenue Growth: +2.96%
• P/S Ratio: 6.71
• Revenue / Employee: 1.30M
• Employees: 668
• Market Cap: 5.85B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	825.40M	-94.61M	-10.28%
Dec 31, 2023	920.01M	53.29M	6.15%
Dec 31, 2022	866.73M	56.94M	7.03%
Dec 31, 2021	809.78M	1.14M	0.14%
Dec 31, 2020	808.64M	-257.28M	-24.14%